Explore Noninvasive Rejection Monitoring in Single Lung Transplantation; A SLAM Study Overview, Presented by Natera
Published 14 November 2024
In this episode of the ISHLT Voices podcast, hosted by Natera, you’ll hear a discussion on the need for noninvasive surveillance options for single lung transplantation and the role that the Prospera Lung donor derived cell free DNA (dd-cfDNA) test can play from the following speakers:
Justin Rosenheck, DO
Assistant Professor of Internal Medicine
Ohio State University | Columbus, OH USA
Ambalavanan Arunachalam, MD
Assistant Professor, Medicine (Pulmonary and Critical Care),
Northwestern Medicine | Chicago, IL USA
There are inherent, increased risks and challenges associated with the management of single lung transplantation over double lung. Monitoring through invasive transbronchial biopsy procedures (TBBx) is often not the best option for these high-risk, frail patients.
In this podcast, notable transplant pulmonologists, Drs. Rosenheck and Arunachalam highlight the need in the single lung population for noninvasive surveillance options. The Prospera Lung donor derived cell free DNA (dd-cfDNA) test has been validated in single and double lung transplants with emerging data in support of clinical utility. The expert speakers also discuss the recently published data in support of dd-cfDNA usage in the single lung transplant population from the SLAM study.
The content of this podcast was developed entirely by our industry partner, Natera. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.
This episode was created for ISHLT Voices and sponsored by Natera.
Listen Now